XBKK
PR9
Market cap490mUSD
Nov 12, Last price
20.80THB
Name
Praram 9 Hospital PCL
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Praram 9 Hospital Public Company Limited manages Praram 9 Hospital, a prominent medical institution located in Thailand. This facility delivers a broad spectrum of tertiary healthcare services, encompassing health promotion, preventative medicine, thorough diagnosis, effective treatment, and comprehensive rehabilitation. Its core medical specialties include obstetrics and gynecology, general surgery, internal medicine, pediatrics, advanced kidney transplantation, cardiovascular care, and orthopedics. The hospital further distinguishes itself with numerous specialized centers, addressing areas such as diabetes and metabolic conditions, gastroenterology and hepatobiliary issues, neurological disorders, routine health check-ups, urgent care, physical therapy and rehabilitation, advanced imaging (radiology), ophthalmology, otolaryngology (ear, nose, and throat), dentistry, mental well-being, dermatology and cosmetic procedures, breast health, joint care, spinal conditions, allergy management, oncology, sleep disorders, pulmonary and respiratory diseases, wellness programs, and LASIK eye surgery. Established in 1992, the company maintains its primary base of operations in Bangkok, Thailand.
Valuation
Title THB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||